FDA.reportPublic FDA data

NDC 63629-2162-01 - Cholestyramine

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
63629-2162
Requested NDC
63629-2162-01
Package NDCs from labels
63629-2162-1, 63629-2162-01
Manufacturer
Bryant Ranch Prepack
Effective date
2026-07-13
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Cholestyramine - Bryant Ranch PrepackBryant Ranch Prepack2026-07-13HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63629-2162-1Cholestyramine210 g in 1 CANPOWDER, FOR SUSPENSION210104

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63629-2162CHOLESTYRAMINE POWDER, FOR SUSPENSION [BRYANT RANCH PREPACK]104Current NDC, Legacy NDC, 1 package rows20231202_b26a13e9-42a2-4869-a00a-672bb1ac4742.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63629-2162-1GM - Gram63629-2162688aceac-5e38-4c26-a2a2-3ccd5b5e5d6c12021-07-15

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 8 · 153 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
cholestyramine powder for suspensionCHOLESTYRAMINE POWDER FOR SUSPENSIONBryant Ranch Prepack31d04422-f159-42ba-8eb5-b0ec1dbc52f92026-08-26Adverse reactionsExact identifier
rxcui: 848943
unii: 4B33BGI082
cholestyramine powder for suspensionCHOLESTYRAMINE POWDER FOR SUSPENSIONBryant Ranch Prepack408ad775-9a1b-43cc-b122-226ade73e0c22026-08-25Adverse reactionsExact identifier
rxcui: 848943
unii: 4B33BGI082
CholestyramineCHOLESTYRAMINEAiPing Pharmaceutical, Inc.214ea05f-de81-4026-9df9-4ce3820668ee2026-08-20Adverse reactionsExact identifier
rxcui: 848943
unii: 4B33BGI082
AdaptopathADENOSINUM CYCLOPHOSPHORICUM, ALPHA-LIPOICUM ACIDUM, ARGENTUM METALLICUM, AVENA SATIVA, CAPSICUM ANNUUM, CITRICUM ACIDUM, COENZYME A, CUPRUM METALLICUM, GINKGO BILOBA, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HYPOTHALAMUS (BOVINE), IODIUM, LEDUM PALUSTRE, MANGANUM ACETICUM, NADIDUM, NATRUM CARBONICUM, OLEUM MORRHUAE, PHOSPHORICUM ACIDUM, PICRICUM ACIDUM, RIBOFLAVINUM, SELENIUM METALLICUM SEPIA, SILICEA, THIAMINUM HYDROCHLORICUM, THYROIDINUM (BOVINE), VANADIUM METALLICUMEnergetix Corporation41234598-0cb5-41c2-bfbe-1c15ee9bf5022026-08-11WarningsExact identifier
unii: XF417D3PSL
Aller-Chord AALFALFA, ALLIUM CEPA, AMBROSIA ARTEMISIAEFOLIA, BRYONIA (ALBA), CITRICUM ACIDUM, COUMARINUM, EUPHRASIA OFFICINALIS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, JUNIPERUS COMMUNIS, MUCOSA NASALIS SUIS, NATRUM SULPHURICUM, PHOSPHORUS, POTHOS FOETIDUS, PULSATILLA (VULGARIS), SOLIDAGO VIRGAUREA, SULPHUR, TANACETUM VULGARE, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSEEnergetix Corporation09e89c92-112d-4320-9df5-b9f938bb90952026-08-11WarningsExact identifier
unii: XF417D3PSL
Hepatic-ToneCARDUUS MARIANUS, CEANOTHUS AMERICANUS, CHELIDONIUM MAJUS, CHIONANTHUS VIRGINICA, CITRICUM ACIDUM, CYSTEINUM, HEPAR SUIS, LEPTANDRA VIRGINICA, MAGNESIA MURIATICA, NATRUM SULPHURICUM, NUX VOMICA, PHOSPHORUS, QUASSIA (AMARA), TARAXACUM OFFICINALEEnergetix Corporationd5f61f13-7e9f-4e46-8ad8-0336f36288df2026-08-11WarningsExact identifier
unii: XF417D3PSL
Isopathic Phenolic RingsHOMEOPATHIC LIQUIDEnergetix Corporation98a7ca26-ccb7-43c7-bd65-892fcbacc8822026-08-11WarningsExact identifier
unii: XF417D3PSL
MetabopathADENOSINUM CYCLOPHOSPHORICUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, BERBERIS VULGARIS, CITRICUM ACIDUM, COENZYME A, DNA, FUMARICUM ACIDUM, GLYCYRRHIZA GLABRA, HEPAR SULPHURIS CALCAREUM, LAPPA MAJOR, MAGNESIA PHOSPHORICA, MANGANUM ACETICUM, NADIDUM, NATRUM MURIATICUM, NATRUM OXALACETICUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PULSATILLA, PYRIDOXINUM HYDROCHLORICUM, RHAMNUS PURSHIANA, RIBOFLAVINUM, RNA, SILICEA, SUCCINICUM ACIDUM, SULPHUR, THIAMINUM HYDROCHLORICUM,Energetix Corporation58bfe670-d308-45a2-8046-7897b62214522026-08-11WarningsExact identifier
unii: XF417D3PSL
cholestyramine powder for suspensionCHOLESTYRAMINE POWDER FOR SUSPENSIONBryant Ranch Prepack5238dc45-a2b7-4208-b1a7-cc695b6cd1f02026-08-10Adverse reactionsExact identifier
rxcui: 848943
unii: 4B33BGI082
XenletaLEFAMULIN ACETATEMeitheal Pharmaceuticals Inc.eb972ea8-7502-422e-84bb-66cb8e93ca062026-07-22Warnings, Adverse reactionsExact identifier
unii: XF417D3PSL
CholestyramineCHOLESTYRAMINEBryant Ranch Prepackcc447b99-e654-42dd-8cf1-f9e7952a25cd2026-07-16Warnings, Adverse reactionsExact identifier
rxcui: 848943
unii: 4B33BGI082
CholestyramineCHOLESTYRAMINEBryant Ranch Prepackb26a13e9-42a2-4869-a00a-672bb1ac47422026-07-13Warnings, Adverse reactionsExact identifier
application number: ANDA077203
ndc (package): 63629-2162-1
ndc (product): 63629-2162
ndc11 (package): 63629216201
rxcui: 1801279
spl id: 9f120f5e-1a69-4654-96d7-e853b6f2a8ee
spl set id: b26a13e9-42a2-4869-a00a-672bb1ac4742
unii: 4B33BGI082
CholestyramineCHOLESTYRAMINEBryant Ranch Prepack2998a314-deb2-4a02-afab-7e8c868888e22026-07-13Warnings, Adverse reactionsExact identifier
rxcui: 848943
unii: 4B33BGI082
cholestyramine powder for suspensionCHOLESTYRAMINE POWDER FOR SUSPENSIONAscend Laboratories, LLC430ac07e-8524-4dec-a599-b7ebc56d95632026-07-10Adverse reactionsExact identifier
rxcui: 848943
unii: 4B33BGI082
Choleystyramine LightCHOLEYSTYRAMINE LIGHTAscend Laboratories, LLC4c9d4561-d5b5-463b-ac57-1bc4d84d135d2026-06-29Warnings, Adverse reactionsExact identifier
rxcui: 1801279
unii: 4B33BGI082
E-Z-GAS IIANTACID/ANTIFLATULENTE-Z-EM, INC.4e12e1cb-b033-076d-e054-00144ff8d46c2026-06-15WarningsExact identifier
unii: XF417D3PSL
CholestyramineCHOLESTYRAMINEPar Health USA, LLCb0c65058-22c3-4f57-9b61-9bc6fcd6e2402026-06-15Warnings, Adverse reactionsExact identifier
application number: ANDA077203
ndc (product): 49884-466
rxcui: 848943
rxcui: 1801279
spl id: 587586f5-0b75-4dc8-b78d-477a66e0cb30
spl set id: b0c65058-22c3-4f57-9b61-9bc6fcd6e240
unii: 4B33BGI082
CHOLESTYRAMINECHOLESTYRAMINEEPIC PHARMA, LLCd02eca8c-18d4-4b11-bb16-08748543b04d2026-06-15Adverse reactionsExact identifier
rxcui: 848943
unii: 4B33BGI082
CHOLESTYRAMINE LIGHTCHOLESTYRAMINE LIGHTEPIC PHARMA, LLC00990dec-7618-4cc8-9387-48c2cea8df1c2026-06-15Warnings, Adverse reactionsExact identifier
rxcui: 1801279
unii: 4B33BGI082
Sodium Citrate and Citric AcidSODIUM CITRATE AND CITRIC ACID MONOHYDRATECardinal Health 107, LLCb3d5225c-0ee4-481e-b9ec-bc5e1321096d2026-06-12Adverse reactionsExact identifier
unii: XF417D3PSL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.